Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-25 4:02 pm Purchase | 2021-03-15 | 13G | Silver Spike Acquisition Corp II SPKBU | Citadel Advisors LLC | 2,114,094 7.400% | 2,114,094 (New Position) | Filing History |
| 2021-03-25 4:01 pm Purchase | 2021-03-15 | 13G | Gaming & Hospitality Acquisition Corp. GHACU | Citadel Advisors LLC | 1,152,333 5.500% | 1,152,333 (New Position) | Filing History |
| 2021-03-22 4:04 pm Purchase | 2021-03-12 | 13G | COLONNADE ACQUISITION CORP II CLAAU | Citadel Advisors LLC | 2,571,701 7.800% | 2,571,701 (New Position) | Filing History |
| 2021-03-22 4:02 pm Purchase | 2021-03-12 | 13G | Vector Acquisition Corporation II VAQC | Citadel Advisors LLC | 2,750,009 6.000% | 2,750,009 (New Position) | Filing History |
| 2021-03-15 7:54 pm Purchase | 2021-03-03 | 13G | Millendo Therapeutics, Inc. MLND | Citadel Advisors LLC | 61,777 4.900% | 61,777 (New Position) | Filing History |
| 2021-03-15 4:42 pm Purchase | 2021-03-04 | 13G | FINTECH EVOLUTION ACQUI CORP U FTEVU | Citadel Advisors LLC | 1,281,547 4.700% | 1,281,547 (New Position) | Filing History |
| 2021-03-15 4:04 pm Purchase | 2021-03-05 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,396,871 5.100% | 1,396,871 (New Position) | Filing History |
| 2021-03-12 4:02 pm Purchase | 2021-03-02 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU | Citadel Advisors LLC | 776,710 5.600% | 776,710 (New Position) | Filing History |
| 2021-03-08 4:01 pm Purchase | 2021-02-25 | 13G | Velocity Acquisition Corp. VELOU | Citadel Advisors LLC | 1,699,966 7.400% | 1,699,966 (New Position) | Filing History |
| 2021-03-01 4:01 pm Purchase | 2021-02-17 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,788,443 7.400% | 1,788,443 (New Position) | Filing History |
| 2021-02-22 4:01 pm Purchase | 2021-02-10 | 13G | Genfit S.A. GNFT | Citadel Advisors LLC | 462,177 1.200% | 462,177 (New Position) | Filing History |
| 2021-02-19 4:03 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 147,100 8.100% | 147,100 (New Position) | Filing History |
| 2021-02-18 4:01 pm Purchase | 2021-02-08 | 13G | Itiquira Acquisition Corp. ITQRU | Citadel Advisors LLC | 1,150,662 5.000% | 1,150,662 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Applied Optoelectronics, Inc. AAOI | Citadel Advisors LLC | 1,965,107 7.900% | -115,842 (-5.57%) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA | Citadel Advisors LLC | 364,785 2.100% | -652,697 (-64.15%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Citadel Advisors LLC | 2,136,115 5.600% | 15,782 (+0.74%) | Filing History |
| 2021-02-16 4:30 pm Unchanged | 2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 22,690 7.300% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Citadel Advisors LLC | 25,487 0.200% | -512,178 (-95.26%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | CAPITOL INVT CORP V COM CAP | Citadel Advisors LLC | 1,869,059 5.400% | 1,869,059 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Simplify China A Shares PLUS Income ETF CAS | Citadel Advisors LLC | 1,250,082 5.400% | 1,250,082 (New Position) | Filing History |